中文名 | Tariquidar (methanesulfonate, hydrate) |
英文名 | Tariquidar (methanesulfonate, hydrate) |
别名 | P-糖蛋白抑制剂 化合物 T13087 他立喹达二甲磺酸盐六水合物 TARIQUIDAR 二甲磺酸盐六水合物 |
英文别名 | XR9576 XR-9576 XR 9576 Tariquidar methanesulfonate XR9576 methanesulfonate, hydrate TARIQUIDAR METHANESULFONATE HYDRATE Tariquidar (methanesulfonate, hydrate) Tariquidar (Methanesulfonate, hydrate) Tariquidar dimethanesulfonate hexahydrate Tariquidar methanesulfonate hydrate (XR9576) N-[2-({4-[2-(6,7-Dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]phenyl}carbamoyl)-4,5-dimethoxyphenyl]-3-quinolinecarboxamide |
CAS | 625375-83-9 |
化学式 | C40H52N4O15S2 |
分子量 | 892.98868 |
溶解度 | DMSO: ≥ 296 mg/mL; H2O: < 8.9 mg/mL |
存储条件 | -20℃ |
体外研究 | Tariquidar methanesulfonate, hydrate (XR9576 methanesulfonate, hydrate) is a potent modulator of P-gp mediated [ 3 H]-Vinblastine and [ 3 H]-Paclitaxel transport as it increases the steady-state accumulation of these cytotoxics in CH r B30 cells to levels observed in non-P-gp-expressing AuxB1 cells (EC 50 =487±50 nM). [ 3 H]-Tariquidar binds to CH r B30 membranes with the highest affinity (K d =5.1±0.9 nM, n=7) and a binding capacity (B max ) of 275±15 pmol/mg membrane protein. In contrast to the parental cell line, the accumulation of [ 3 H]-Vinblastine is increased in a dose-dependent fashion by the modulators XR9576 (EC 50 =487±50 nM). The MDR modulator Tariquidar is able to inhibit 60-70% of the vanadate-sensitive ATPase activity, with potent IC 50 value of 43±9 nM. Tariquidar (XR9576) potentiates the cytotoxicity of several drugs including Doxorubicin, Paclitaxel, Etoposide, and Vincristine; complete reversal of resistance is achieved in the presence of 25-80 nM Tariquidar. Tariquidar is a potent inhibitor of photoaffinity labeling of P-gp by [ 3 H]Azidopine implying a direct interaction with the protein. |
体内研究 | In mice bearing the intrinsically resistant MC26 colon tumors, coadministration of Tariquidar methanesulfonate, hydrate (XR9576 methanesulfonate, hydrate) potentiates the antitumor activity of Doxorubicin without a significant increase in toxicity; maximum potentiation is observed at 2.5-4.0 mg/kg dosed either i.v. or p.o. In addition, coadministration of Tariquidar (6-12 mg/kg p.o.) fully restores the antitumor activity of Paclitaxel, Etoposide, and Vincristine against two highly resistant MDR human tumor xenografts (2780AD, H69/LX4) in nude mice. Tariquidar is found to also significantly potentiate the antitumor activity of doxorubicin against s.c. MC26 tumors in vivo. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.12 ml | 5.599 ml | 11.198 ml |
5 mM | 0.224 ml | 1.12 ml | 2.24 ml |
10 mM | 0.112 ml | 0.56 ml | 1.12 ml |
5 mM | 0.022 ml | 0.112 ml | 0.224 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!